STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Point72 Group Discloses 5.5% Ownership in Kodiak Sciences (KOD)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Kodiak Sciences Inc. Schedule 13G filed by Point72-related filers reports collective beneficial ownership of 2,908,836 shares of Kodiak Sciences common stock, representing 5.5% of the class as of the close of business on August 18, 2025. The filing attributes shared voting and shared dispositive power of all reported shares to Point72 Asset Management, Point72 Capital Advisors, Inc., and Steven A. Cohen, with no sole voting or dispositive power reported. Point72 Associates holds the shares and Point72 Asset Management acts as investment manager; Point72 Capital Advisors is the general partner and Mr. Cohen controls the entities. The filers state the shares were not acquired to change or influence control of the issuer. A Joint Filing Agreement is filed as Exhibit 99.1.

Positive

  • Transparent reporting of ownership percentage and exact share count (2,908,836 shares, 5.5%)
  • Joint Filing Agreement filed as Exhibit 99.1 clarifying coordination among filers
  • Explicit statement that the position is not held to change or influence control

Negative

  • None.

Insights

TL;DR: Point72 group reports a 5.5% shared stake in KOD with shared voting and dispositive power as of 8/18/2025.

The Schedule 13G discloses a passive-ownership filing by Point72 entities and Steven A. Cohen for 2,908,836 shares (5.5%) of Kodiak Sciences common stock. Ownership is reported as shared voting and shared dispositive power, indicating control is exercised through the investment fund structure rather than individually. The filers expressly state the position is not intended to influence control. For investors, this documents a notable institutional stake without an active control intent; the filing is consistent with passive reporting under applicable rules.

TL;DR: Joint filing clarifies organizational relationships and control lines among Point72 entities and Mr. Cohen.

The filing clarifies that Point72 Associates holds the shares, Point72 Asset Management has investment and voting power as manager, Point72 Capital Advisors is the general partner, and Steven A. Cohen controls the reporting entities. The Joint Filing Agreement (Exhibit 99.1) formalizes the consolidated disclosure. The absence of sole voting or dispositive power and the certification regarding non-control intent are material governance disclosures that signal a passive ownership posture while documenting potential shared decision pathways.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Point72 Asset Management, L.P.
Signature:/s/ Jason M. Colombo
Name/Title:Jason M. Colombo, Authorized Person
Date:08/19/2025
Point72 Capital Advisors, Inc.
Signature:/s/ Jason M. Colombo
Name/Title:Jason M. Colombo, Authorized Person
Date:08/19/2025
Steven A. Cohen
Signature:/s/ Jason M. Colombo
Name/Title:Jason M. Colombo, Authorized Person
Date:08/19/2025
Exhibit Information

Exhibit 99.1: Joint Filing Agreement

FAQ

How many Kodiak Sciences (KOD) shares does Point72 report owning?

Point72 Asset Management, Point72 Capital Advisors, and Steven A. Cohen report beneficial ownership of 2,908,836 shares, representing 5.5% of the class as of August 18, 2025.

Does Point72 have sole voting or dispositive power over the KOD shares?

No. The filing reports 0 sole voting power and 0 sole dispositive power; all reported power is shared.

What entities are involved in the Schedule 13G filing for KOD?

The filing is made by Point72 Asset Management, L.P., Point72 Capital Advisors, Inc., and Steven A. Cohen, with shares held by Point72 Associates.

As of what date is the ownership reported?

The ownership figures are reported as of the close of business on August 18, 2025.

Did the filers state an intent to influence control of Kodiak Sciences?

Yes. The filers certify that the securities were not acquired and are not held to change or influence control of the issuer.
Kodiak Sciences Inc.

NASDAQ:KOD

KOD Rankings

KOD Latest News

KOD Latest SEC Filings

KOD Stock Data

1.16B
49.50M
5.52%
79.26%
5.51%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
PALO ALTO